Lead Product(s) : Chlordiazepoxide,Clidinium
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Dr Reddy's Labs Receives US FDA Approval for Generic Librax
Details : The Librax brand and generic market had US sales of approximately $105.9 million MAT for the most recent twelve months ending in July 2021 according to IQVIA Health.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 31, 2021
Lead Product(s) : Chlordiazepoxide,Clidinium
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chlordiazepoxide,Amitriptyline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Study Phase : Approved FDF
Sponsor : MedQuímica Indústria Farmacêutica
Deal Size : Undisclosed
Deal Type : Acquisition
Lupin's Brazil Subsidiary Acquires 9 Brands From Bausch Health
Details : As part of the transaction, MedQuímica will acquire rights to nine products including Limbitrol, Melleril and Dalmadorm for Central Nervous System related conditions, Bacrocin, Glyquin, Solaquin, Oxipelle™ and Efurix as topical oncological treatments.
Product Name : Limbitrol
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
November 28, 2022
Lead Product(s) : Chlordiazepoxide,Amitriptyline Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Approved FDF
Sponsor : MedQuímica Indústria Farmacêutica
Deal Size : Undisclosed
Deal Type : Acquisition
Reset All
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
